EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Engineered chimeric T7 RNA polymerase improves salt tolerance and reduces dsRNA impurity generation during in vitro transcription of mRNA

Athul Sanjeev, Caroline Reiss Summers iD, Jason Politi, Penny J Beuning, Christopher J Cheng

Nucleic Acids Research · 2025

DOI: 10.1093/nar/gkaf1124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Athul Sanjeev und 4 weiteren Autor:innen. Beteiligte Einrichtung: Verve Therapeutics, Boston, MA 02215, United States. Hauptthemen laut MEDLINE: Bacteriophage T7, DNA-Directed RNA Polymerases, Protein Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Verve Therapeutics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Messenger RNA (mRNA) is typically produced enzymatically through in vitro transcription using wild-type T7 RNA polymerase; however, this enzyme is also known to generate double-stranded RNA (dsRNA) impurities during transcription. These impurities may evoke an immune response, potentially reducing the therapeutic index of the drug product. Upstream and downstream approaches may be used to mitigate the formation or removal of such dsRNA impurities. However, these processes can be costly, reduce yield, and be challenging to scale for clinical manufacturing. In this work, we engineered a chimeric T7 RNA polymerase by tethering a DNA-binding domain to increase the selectivity of the polymerase for DNA templates and found that it was capable of reducing dsRNA formation. The chimeric T7 RNA polymerase reduced dsRNA levels by three- to four-fold relative to wild-type T7 RNA polymerase with commensurate reduction in immune stimulation in vitro. Additionally, the chimeric T7 RNA polymerase showed improved salt tolerance and was active at NaCl concentrations up to 150 mM, which is otherwise a restrictive condition for wild-type T7 polymerase. These features make this novel enzyme an attractive option for addressing various challenges facing the field of mRNA manufacturing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacteriophage T7DNA-Directed RNA PolymerasesProtein EngineeringRNA, MessengerRNA, Double-StrandedSodium ChlorideProtein DomainsRecombinant Proteins

Substanzen

DNA-Directed RNA PolymerasesRNA, MessengerRNA, Double-StrandedSodium ChlorideRecombinant Proteins

Autor:innen und Institutionen

  • Verve Therapeutics, Boston, MA 02215, United States.
  • Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA 02115, United States.

ORCID-Profile: Caroline Reiss Summers

Förderung

  • Verve Therapeutics

Zitieren

APA

Sanjeev, A., Summers, C. R., Politi, J., Beuning, P. J., & Cheng, C. J. (2025). Engineered chimeric T7 RNA polymerase improves salt tolerance and reduces dsRNA impurity generation during in vitro transcription of mRNA. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf1124

Vancouver

Sanjeev A, Summers CR, Politi J, Beuning PJ, Cheng CJ. Engineered chimeric T7 RNA polymerase improves salt tolerance and reduces dsRNA impurity generation during in vitro transcription of mRNA. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf1124

BibTeX
@article{Sanjeev2025,
  author = {Sanjeev, Athul and Summers, Caroline Reiss and Politi, Jason and Beuning, Penny J and Cheng, Christopher J},
  title = {Engineered chimeric T7 RNA polymerase improves salt tolerance and reduces dsRNA impurity generation during in vitro transcription of mRNA},
  journal = {Nucleic Acids Research},
  year = {2025},
  doi = {10.1093/nar/gkaf1124}
}
Kostenlos starten →